Eliza Flanagan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eliza Flanagan has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Carl Cosgrave
University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia, barwonhealth.org.au
1 shared publication Cindy Ho
Department of Gastroenterology and Hepatology Monash Health Melbourne Victoria Australia
1 shared publicationDamian Dowling
Department Cof Gastroenterology, University Hospital Geelong, Victoria, Australia
1 shared publicationEdward Saxby
Department of Gastroenterology and Hepatology Monash Health Melbourne Victoria Australia
1 shared publicationJulianne Grant
Department of Gastroenterology and Hepatology Monash Health Melbourne Victoria Australia
1 shared publication- Kai Chaivannacoopt
Respiratory Department University Hospital Geelong Geelong Australia
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (10)
Gastric Outlet Obstruction Secondary to Cholecystoduodenal Fistula With Gallstone-Induced Extrinsic Duodenal Compression
Gastric outlet obstruction (GOO) caused by gallstone disease is rare and typically results from the Bouveret syndrome, with intraluminal gallstone impaction following cholecystoenteric fistula formation. We report a 69-year-old woman with GOO caused by extrinsic duodenal compression from a gallstone retained within a contracted gallbladder adjacent to a cholecystoduodenal fistula, without intraluminal migration or biliary obstruction. Computed tomography, magnetic resonance cholangiopancreatography, endoscopy, and endoscopic ultrasound (EUS) established the diagnosis, with EUS guiding fistula dilation, drainage, and stent placement. Symptoms improved without definitive stone extraction, although malnutrition persisted. This case represents an atypical intermediate phenotype between the Bouveret and Mirizzi syndromes and highlights the therapeutic value of EUS.
- 25 September 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (10)
Open AccessGastric Outlet Obstruction Secondary to Cholecystoduodenal Fistula With Gallstone-Induced Extrinsic Duodenal Compression
Gastric outlet obstruction (GOO) caused by gallstone disease is rare and typically results from the Bouveret syndrome, with intraluminal gallstone impaction following cholecystoenteric fistula formation. We report a 69-year-old woman with GOO caused by extrinsic duodenal compression from a gallstone retained within a contracted gallbladder adjacent to a cholecystoduodenal fistula, without intraluminal migration or biliary obstruction. Computed tomography, magnetic resonance cholangiopancreatography, endoscopy, and endoscopic ultrasound (EUS) established the diagnosis, with EUS guiding fistula dilation, drainage, and stent placement. Symptoms improved without definitive stone extraction, although malnutrition persisted. This case represents an atypical intermediate phenotype between the Bouveret and Mirizzi syndromes and highlights the therapeutic value of EUS.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2025 (1)
Kava Herb‐Induced Liver Injury as Verified by the Updated RUCAM
A temporal relationship between liver enzyme derangement and an herbal remedy warrants further assessment for herb‐induced liver injury (HILI). Here, we describe the use of kava, a drink traditionally consumed in Pacific Island cultures, causing acute ALT and AST elevation as assessed by an updated RUCAM score of 7. The increasing use of kava in Western society should prompt clinicians to be more aware of this rare cause of HILI. A 46‐year‐old man was referred to the emergency department with a 3‐week history of fatigue, right upper quadrant pain, and profound transaminitis. He commenced kava 10 g daily 5 weeks prior to aid sleep, which was ceased 2 weeks prior due to his biochemical derangement. Blood tests revealed an ALT of 1546 U/L and an AST of 920 U/L. An autoimmune screen, viral serology, and liver ultrasound showed no abnormalities. A liver biopsy revealed foci of hepatocellular necrosis with scattered ballooning degeneration and apoptotic bodies in the parenchyma, but normal underlying hepatic parenchyma without steatosis. Following cessation of kava, the liver enzymes improved without any other intervention. He was monitored as an outpatient and had no recurrence. The incidence of kava HILI may increase with its marketing; its exact mechanism is unknown. Ultimately, further research is needed to identify the pathogenesis of kava HILI. HILI is a significant cause of transaminitis, and clinicians should remain vigilant in patients presenting with nonspecific symptoms and a negative liver screen.
- 1 January 2025
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2025 (1)
Open AccessKava Herb‐Induced Liver Injury as Verified by the Updated RUCAM
A temporal relationship between liver enzyme derangement and an herbal remedy warrants further assessment for herb‐induced liver injury (HILI). Here, we describe the use of kava, a drink traditionally consumed in Pacific Island cultures, causing acute ALT and AST elevation as assessed by an updated RUCAM score of 7. The increasing use of kava in Western society should prompt clinicians to be more aware of this rare cause of HILI. A 46‐year‐old man was referred to the emergency department with a 3‐week history of fatigue, right upper quadrant pain, and profound transaminitis. He commenced kava 10 g daily 5 weeks prior to aid sleep, which was ceased 2 weeks prior due to his biochemical derangement. Blood tests revealed an ALT of 1546 U/L and an AST of 920 U/L. An autoimmune screen, viral serology, and liver ultrasound showed no abnormalities. A liver biopsy revealed foci of hepatocellular necrosis with scattered ballooning degeneration and apoptotic bodies in the parenchyma, but normal underlying hepatic parenchyma without steatosis. Following cessation of kava, the liver enzymes improved without any other intervention. He was monitored as an outpatient and had no recurrence. The incidence of kava HILI may increase with its marketing; its exact mechanism is unknown. Ultimately, further research is needed to identify the pathogenesis of kava HILI. HILI is a significant cause of transaminitis, and clinicians should remain vigilant in patients presenting with nonspecific symptoms and a negative liver screen.
- Open Access
- 30 July 2024
- Published by Wiley in Internal Medicine Journal
- Vol. 54 (10) , 1678-1685
Identify, screen and treat via electronic pathway: a semiautomated approach to retriaging a liver clinic waitlist
Background: Long specialist outpatient waiting lists are a source of clinical risk. Triage assignment is based on subjective assessment of referrals and fails to account for dynamic changes in disease status while patients await clinical review.Aims: To pilot an innovative triage method using a trifold approach to conduct noninvasive assessment of fibrosis and to determine the feasibility of reflex hepatitis C virus (HCV) polymerase chain reaction (PCR) testing.Methods: A total of 1006 patients awaiting an initial liver clinic appointment at a tertiary Australian hospital were sent a short message service (SMS) requesting a blood test be completed. The first 60 patients received an SMS only, and the subsequent 946 patients also received a phone call from a Liver Care Guide (LCG), a nonclinician employed to increase patient engagement. Liver fibrosis assessment through noninvasive testing was performed using an aspartate aminotransferase to platelet ratio index (APRI) and fibrosis‐4 (FIB4) score. Patients with an APRI ≥1, FIB4 ≥3.25 or positive HCV PCR were retriaged to Category 1.Results: Four hundred ninety (49%) patients completed testing and 40 (4%) were triaged to Category 1. Subanalyses demonstrated increased response rates with LCG input (P = 0.012). Retriaged patients had been on the waitlist for a median of 216 days, exceeding initial category recommendations.Conclusion: This study successfully implemented a semiautomated strategy that prioritises patients with probable advanced liver disease or active HCV, demonstrating enhanced patient engagement with LCG support. It highlights the burden of patients referred for specialist care and the need for innovative strategies for monitoring and objective risk stratification.
- 30 July 2024
- Published by Wiley in Internal Medicine Journal
- Vol. 54 (10) , 1678-1685
Open AccessIdentify, screen and treat via electronic pathway: a semiautomated approach to retriaging a liver clinic waitlist
Background: Long specialist outpatient waiting lists are a source of clinical risk. Triage assignment is based on subjective assessment of referrals and fails to account for dynamic changes in disease status while patients await clinical review.Aims: To pilot an innovative triage method using a trifold approach to conduct noninvasive assessment of fibrosis and to determine the feasibility of reflex hepatitis C virus (HCV) polymerase chain reaction (PCR) testing.Methods: A total of 1006 patients awaiting an initial liver clinic appointment at a tertiary Australian hospital were sent a short message service (SMS) requesting a blood test be completed. The first 60 patients received an SMS only, and the subsequent 946 patients also received a phone call from a Liver Care Guide (LCG), a nonclinician employed to increase patient engagement. Liver fibrosis assessment through noninvasive testing was performed using an aspartate aminotransferase to platelet ratio index (APRI) and fibrosis‐4 (FIB4) score. Patients with an APRI ≥1, FIB4 ≥3.25 or positive HCV PCR were retriaged to Category 1.Results: Four hundred ninety (49%) patients completed testing and 40 (4%) were triaged to Category 1. Subanalyses demonstrated increased response rates with LCG input (P = 0.012). Retriaged patients had been on the waitlist for a median of 216 days, exceeding initial category recommendations.Conclusion: This study successfully implemented a semiautomated strategy that prioritises patients with probable advanced liver disease or active HCV, demonstrating enhanced patient engagement with LCG support. It highlights the burden of patients referred for specialist care and the need for innovative strategies for monitoring and objective risk stratification.
- Open Access
- 2 September 2022
- Published by Wiley in Respirology Case Reports
- Vol. 10 (10) , e01033
ANCAnegative eosinophilic granulomatosis with polyangiitis (EGPA) presenting with left ventricular thrombus: An appreciation of distinct phenotypes and eosinophilic driven pathogenesis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare multisystem disorder, included in the spectrum of the antineutrophil cytoplasmic antibodies (ANCA) associated vasculitides. There are heterogeneous clinical features and a lack of consensus in standardized diagnostic criteria, with an underappreciation of eosinophilic manifestations. There are now reported phenotypical differences betweenANCA‐positive and negativeEGPA, with myocardial involvement, lung infiltrates and gastrointestinal symptoms predominating inANCA‐negative cases. We report a rare presentation ofANCA‐negativeEGPAin a woman with respiratory, neurological and cardiac involvement, manifesting as a large left ventricular thrombus without significant cardiac dysfunction.
- 2 September 2022
- Published by Wiley in Respirology Case Reports
- Vol. 10 (10) , e01033
Open AccessANCAnegative eosinophilic granulomatosis with polyangiitis (EGPA) presenting with left ventricular thrombus: An appreciation of distinct phenotypes and eosinophilic driven pathogenesis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare multisystem disorder, included in the spectrum of the antineutrophil cytoplasmic antibodies (ANCA) associated vasculitides. There are heterogeneous clinical features and a lack of consensus in standardized diagnostic criteria, with an underappreciation of eosinophilic manifestations. There are now reported phenotypical differences betweenANCA‐positive and negativeEGPA, with myocardial involvement, lung infiltrates and gastrointestinal symptoms predominating inANCA‐negative cases. We report a rare presentation ofANCA‐negativeEGPAin a woman with respiratory, neurological and cardiac involvement, manifesting as a large left ventricular thrombus without significant cardiac dysfunction.
- 1 March 2021
- Published by Elsevier in Gastroenterology
- Vol. 160 (4) , e3-e4
An Unusual Cause of Small Intestinal Ulceration
- 1 March 2021
- Published by Elsevier in Gastroenterology
- Vol. 160 (4) , e3-e4
An Unusual Cause of Small Intestinal Ulceration